Sensei Biotherapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview

Faeth Therapeutics,

24/02/2025 14:10

* Sensei Biotherapeutics Inc  SNSE.OQ   SNSE.O  is expected
to show no change in quarterly revenue when it reports 
results on February 26 (estimated) for the period ending
December 31 2024
    * 
    * ​LSEG's mean analyst estimate for Sensei Biotherapeutics
Inc is
for a loss of 28 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sensei
Biotherapeutics Inc is $4.00​, above​ its last closing price
of $0.45. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2024  -0.31       -0.31      -0.29     Beat    7.2
 Jun. 30 2024  -0.30       -0.29      -0.28     Beat    2.9
 Mar. 31 2024  -0.27       -0.27      -0.32     Missed  -16.4​
 Dec. 31 2023  -0.31       -0.31      -0.30     Beat    2.5
 ​​Sep.        -0.34       -0.34      -0.28     Beat    17.4
 30 2023                                                
 Jun. 30 2023  -0.33       -0.33      -0.31     Beat    6.2​
 Mar. 31 2023  -0.36       -0.36      -0.33     Beat    7.3
 Dec. 31 2022  -0.39       -0.40      -0.40     Met     0
 This summary was machine generated February 24 at 14:10 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)